Cargando…
Lithium alters expression of RNAs in a type-specific manner in differentiated human neuroblastoma neuronal cultures, including specific genes involved in Alzheimer’s disease
Lithium (Li) is a medication long-used to treat bipolar disorder. It is currently under investigation for multiple nervous system disorders, including Alzheimer’s disease (AD). While perturbation of RNA levels by Li has been previously reported, its effects on the whole transcriptome has been given...
Autores principales: | Maloney, Bryan, Balaraman, Yokesh, Liu, Yunlong, Chopra, Nipun, Edenberg, Howard J., Kelsoe, John, Nurnberger, John I., Lahiri, Debomoy K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892907/ https://www.ncbi.nlm.nih.gov/pubmed/31797941 http://dx.doi.org/10.1038/s41598-019-54076-3 |
Ejemplares similares
-
Repeated electromagnetic field stimulation lowers amyloid-β peptide levels in primary human mixed brain tissue cultures
por: Perez, Felipe P., et al.
Publicado: (2021) -
Human microRNA (miR-20b-5p) modulates Alzheimer’s disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer’s biomarkers
por: Wang, Ruizhi, et al.
Publicado: (2022) -
MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties
por: Chopra, Nipun, et al.
Publicado: (2020) -
PuF, an antimetastatic and developmental signaling protein, interacts with the Alzheimer’s amyloid-β precursor protein via a tissue-specific proximal regulatory element (PRE)
por: Lahiri, Debomoy K, et al.
Publicado: (2013) -
Novel Nuclear Factor-KappaB Targeting Peptide Suppresses β-Amyloid Induced Inflammatory and Apoptotic Responses in Neuronal Cells
por: Srinivasan, Mythily, et al.
Publicado: (2016)